Trial intelligence / Profile preview

Levodopa withdrawal and re-administration effects on attention in Parkinson's disease

NL-OMON34140Active, not recruiting

Sponsor
Vrije Universiteit Amsterdam
Start
Feb 2011
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of levodopa in Parkinson's disease (PD) (2 arms), sponsored by Vrije Universiteit Amsterdam. Primary endpoints: Response latency, Accuracy and 1 more. Started Feb 2011; status: active, not recruiting.

02

Drugs

levodopa
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NL-OMON34140.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34140.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call